Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: A WWW study

Addictive Behaviors

Volumn 29, Issue 4, 2004, Pages 743-752

  Scholey, Andrew B ^a   Parrott, Andrew C ^b   Buchanan, Tom ^c   Heffernan, Thomas M ^a   Ling, Jonathan ^d   Rodgers, Jacqui ^e  

^a NORTHUMBRIA UNIVERSITY   (United Kingdom)

^b SWANSEA UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF WESTMINSTER   (United Kingdom)

^d TEESSIDE UNIVERSITY   (United Kingdom)

^e NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Ecstasy; Hallucinogens; MDMA; Polydrug use; Stimulants

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; AMPHETAMINE; CANNABIS; CENTRAL STIMULANT AGENT; COCAINE; ILLICIT DRUG; LYSERGIDE; NICOTINE; PSILOCYBINE; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT;

ADULT; ARTICLE; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG PREFERENCE; DRUG USE; FEMALE; FREQUENCY ANALYSIS; HUMAN; LEISURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE DRUG ABUSE; STATISTICAL SIGNIFICANCE; TABLET;

ADULT; ALCOHOL DRINKING; CENTRAL NERVOUS SYSTEM STIMULANTS; FEMALE; HALLUCINOGENS; HUMANS; INTERNET; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; SMOKING; STREET DRUGS; SUBSTANCE-RELATED DISORDERS;

EID: 2342591298     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2004.02.022     Document Type: Article

References (34)

1. Buchanan, T., Ali, T., Heffernan, T. M., Ling, J., Parrott, A., Rodgers, J., & Scholey, A. B. (Submitted). Non-equivalence of online and paper- and -pencil psychological tests: The case of the Prospective Memory Questionnaire.
2. Chang L. Neuroimaging studies in chronic effects of MDMA/Ecstasy use. NIDA Scientific Conference on MDMA/Ecstasy: Advances, challenges, and future directions, National Institute on Drug Abuse, Bethesda, MD, USA. July 2001:2001;20. Program abstract
3. Curran H.V., Travill R.A. Mood and cognitive effects of 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy"): Weekend "high" followed by mid-week "low" Addiction. 92:1997;821-831
4. Davison D., Parrott A.C. Ecstasy in recreational users: Self-reported psychological and physiological effects. Human Psychopharmacology Clinical and Experimental. 12:1997;91-97
5. Fox H., Parrott A.C., Turner J.J.D. Ecstasy/MDMA related cognitive deficits: A function of dosage rather than awareness of problems. Journal of Psychopharmacology. 15:2001;273-281
6. Gouzoulis-Meyfrank E., Daumann J., Tuchtenhagen F., Pelz S., Becker S., Kunert H.J., Fimm B., Sass H. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery and Psychiatry. 68:2000;719-725
7. Green A.R., Cross A.J., Goodwin G.M. Review of the pharmacology and clinical pharmacology of 3, 4-methylenedioxymethamphetamine (MDMA or Ecstasy). Psychopharmacology. 119:1995;247-260
8. Heffernan T.M., Ling J., Scholey A.B. Subjective ratings of prospective memory deficits in MDMA ('ecstasy') users. Human Psychopharmacology Clinical and Experimental. 16:2001;339-344
9. Jansen K.L.R. Ecstasy (MDMA) dependence. Drug and Alcohol Dependence. 53:1999;121-124
10. McCann U.D., Eligulashvili V., Ricaurte G.A. (±) 3, 4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: Clinical studies. Neuropsychobiology. 42:2000;11-16
11. McCann U.D., Slate S.O., Ricaurte G.A. Adverse reactions with 3, 4-methylenedioxymethamphetamine (MDMA; "Ecstasy"). Drug Safety. 15:1996;107-115
12. Merrill J. Ecstasy and neurodegeneration. British Medical Journal. 313:1996;423
13. Morgan M.J. Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology. 141:1999;30-36
14. Morgan M.J. Ecstasy (MDMA): A review of its possible persistent psychological effects. Psychopharmacology. 152:2000;230-248
15. Parrott A.C. Human research on MDMA (3, 4-methylenedioxymethamphetamine) neurotoxicity: Cognitive an behavioral indices of change. Neuropsychobiology. 42:2000;17-24
16. Parrott A.C. Human psychopharmacology of Ecstasy (MDMA): A review of 15 years of empirical research. Human Psychopharmacology Clinical and Experimental. 16:2001;557-577
17. Parrott A.C., Lasky J. Ecstasy (MDMA) effects upon mood and cognition; before, during, and after a Saturday night dance. Psychopharmacology. 139:1998;261-268
18. Parrott A.C., Milani R., Parmar R., Turner J.J.D. Ecstasy polydrug users and other recreational drug users in Britain and Italy: Psychiatric symptoms and psychobiological problems. Psychopharmacology. 159:2001;77-82
19. Parrott A.C., Sisk E., Turner J. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users. Drug and Alcohol Dependence. 60:2000;105-110
20. Pedersen W., Skrondal A. Ecstasy and new patterns of drug use: A normal population study. Addiction. 94:1999;1695-1706
21. Peroutka S.J., Newman H., Harris H. Subjective effects of 3, 4-methylenedioxymethamphetamine in recreational users. Neuropsychopharmacology. 1:1988;273-277
22. Reneman L., Booij J., Majoie C.B.L, van den Brink W., den Heeten G.J. Investigating the potential neurotoxicity of Ecstasy (MDMA): An imaging approach. Human Psychopharmacology Clinical and Experimental. 16:2001;579-588
23. Ricaurte G.A., Bryan G., Strauss L., Seiden L.S., Schuster C.R. Hallucinogenic amphetamine selectively destroys brain serotonin nerve terminals. Science. 229:1985;986-988
24. Ricaurte G.A., Yuan J., McCann U.D. (±) 3, 4- Methylenedioxymethamphetamine (MDMA, "Ecstasy")-induced serotonin neurotoxicity: Studies in animals. Neuropsychobiology. 42:2000;5-10
25. Rodgers J. Cognitive performance amongst recreational users of "ecstasy" Psychopharmacology. 151:2000;19-24
26. Rodgers J., Buchanan T., Scholey A.B., Heffernan T.M., Ling J., Parrott A. Differential effects of ecstasy and cannabis on self reports of memory ability: A web-based study. Human Psychopharmacology Clinical and Experimental. 16:2001;619-625
27. Rodgers J., Buchanan T., Scholey A.B., Heffenan T.M., Ling J., Parrott A.C. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: A web-based study. Journal of Psychopharmacology. 17:2003;389-397
28. Schensul J.J. The diffusion of MDMA use among urban youth in Hartford, Connecticut. NIDA Scientific Conference on 'MDMA/Ecstasy: Advances, challenges, and future directions, ' National Institute on Drug Abuse, Bethesda, July 2001:2001;38. Program abstract
29. Schifano F. Potential human neurotoxicity of MDMA ('Ecstasy'): Subjective self-reports, evidence form an Italian drug addiction centre and clinical case studies. Neuropsychobiology. 42:2000;25-33
30. Schifano F., Di Furia L., Forza G., Minicuci N., Bricolo R. MDMA ('ecstasy') consumption in the context of polydrug abuse: A report on 150 patients. Drug and Alcohol Dependence. 52:1998;85-90
31. Solowij N. Ecstasy (3, 4-methylenedioxymethamphetamine). Current Opinion in Psychiatry. 6:1993;411-415
32. Spruit I.P. Monitoring synthetic drug markets, trends and public health. Substance Use and Misuse. 36:2001;23-47
33. Topp L., Hando J., Dillon P., Roche A., Solowij N. Ecstasy use in Australia: Patterns of use and associated harm. Drug and Alcohol Dependence. 55:1999;105-115
34. Webb E., Ashton C.H., Kelly P., Kamali F. Alcohol and drug use in UK university students. Lancet. 348:1996;922-925